Characterization of Two Parabacteroides distasonis Candidate Strains as New Live Biotherapeutics against Obesity

The gut microbiota is now considered as a key player in the development of metabolic dysfunction. Therefore, targeting gut microbiota dysbiosis has emerged as a new therapeutic strategy, notably through the use of live gut microbiota-derived biotherapeutics. We previously highlighted the anti-inflam...

Descripción completa

Detalles Bibliográficos
Autores principales: Cuffaro, Bernardo, Boutillier, Denise, Desramaut, Jérémy, Jablaoui, Amin, Werkmeister, Elisabeth, Trottein, François, Waligora-Dupriet, Anne-Judith, Rhimi, Moez, Maguin, Emmanuelle, Grangette, Corinne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10177344/
https://www.ncbi.nlm.nih.gov/pubmed/37174660
http://dx.doi.org/10.3390/cells12091260

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10177344/
https://www.ncbi.nlm.nih.gov/pubmed/37174660
http://dx.doi.org/10.3390/cells12091260

Ejemplares similares